William Bowen retweeted
FDA Breakthrough Designation for CTL019 Engineered T Cells lnkd.in/dZku-rt
Alzheimer's R&D suffers as trial failure rate hits an 'astounding' 99.6%: fiercebiotech.com/story/alzh…
1
Deal Aims to Grow “Humanized” Organs in Pigs for Transplantation:
xconomy.com/san-diego/2014/0…
William Bowen retweeted
Congratulations to Professor David Williams, who has been awarded an OBE for services to #science and #engineering http://t.co/B91MqhvkPU
William Bowen retweeted
Aquí uno, que como yo, no tenía a Kittel en la quiniela y pensaba que se iba a retirar. #Tropela #Giro nitter.cf/cyclingswagg/status/46…
William Bowen retweeted
New @_StemBook paper published 'Regulatory challenges for the manufacture and scale-out of autologous cell therapies' http://t.co/QMkWdv6Cy2
William Bowen retweeted
Interesting comment from Warren Buffett at Berkshire meeting today "Self-driving car is a huge threat to auto insurance industry"
William Bowen retweeted
[PHOTO] Dragon at station, while astronauts unpack supplies & science experiments. Photo via @NASA
William Bowen retweeted
Boris Johnson & Steve Bates @BIA_UK promote #MedCity, golden triangle #Biotech cluster London - Cambridge - Oxford telegraph.co.uk/finance/news…
William Bowen retweeted
HLI Launched to Promote Healthy Aging w Advances in Genomics/Stem Cell Therapies humanlongevity.com/human-lon… @Metabolon @UCSDnews @JCVenterInst
William Bowen retweeted
13 years ago my team published the first human genome in the journal science. A new beginning for medicine will soon be announced.
Just registered for Health and Wellbeing Research Conference #HWRC14
William Bowen retweeted
Doris Taylor @Texas_Heart hopes to approach #FDA next year to do first-in-human study with bio-artificial hearts.xconomy.com/texas/2013/10/15… #in
William Bowen retweeted
Replying to @cells_nnm
.@cells_nnm @celltherapy ▸Need for cash &/or IP will drive many M&As & deals between the 700+ #celltherapy co's ▸Sign of a maturing industry
William Bowen retweeted
First heart gene therapy trial begins in UK - we speak to patients & researchers at Royal Brompton hospital - at Six, Ten and online
William Bowen retweeted
Global market for AUTOLOGOUS cell therapy valued at $650M in 2011 with predicted worth of $2.2B by 2017 [CAGR of 21%] http://t.co/cKOakzYFGY
Roche won't pursue Herceptin patents in India fiercepharma.com/story/roche…













